summarized stringlengths 41 385 |
|---|
Monoclonal antibodies rituximab locate cancer cells either kill deliver cancer-killing substances without harming normal cells . Drugs used chemotherapy use different ways kill cancer cells . Combining monoclonal antibody therapy chemotherapy may kill cancer |
MP470 may stop growth cancer cells blocking enzymes needed to grow . MP470 may stop growth cancer cells blocking enzymes needed to grow . |
Interleukin-12 may kill tumor cells stopping blood flow . White blood cells stimulating person's white blood cells kill cancer cells . |
Gossypol given together paclitaxel carboplatin given together paclitaxel carboplatin . Gossypol given together paclitaxel carboplatin treating patients solid tumors metastatic cannot removed surgery . |
This study designed long-term follow-up study participants receive genetically modified autologous CAR-T cells . |
Genetic testing specific enzyme may help doctors determine whether side effects response chemotherapy related person's genetic makeup . Genetic testing specific enzyme may help doctors determine whether side effects response chemotherapy related person's genetic makeup . |
Monoclonal antibodies, rituximab, block cancer growth different ways . Some find cancer cells help kill carry cancer-killing substances . Others interfere ability cancer cells grow spread . |
Phase I trial studying side effects of vorinostat given together decitabine . |
PXD101 bortezomib may stop growth cancer cells blocking enzymes needed cell growth . PXD101 may also cause cancer cells look like normal cells, grow spread slowly . |
Bortezomib may stop growth cancer cells blocking enzymes necessary growth . Bortezomib may increase effectiveness flavopiridol making cancer cells sensitive drug . |
Phase I trial studying side effects of 17-DMAG . Drug is used to treat patients with metastatic unresectable solid tumors lymphomas . |
The purpose study determine rate response drugs bortezomib (Velcade) vorinostat (Zolinza) The purpose study determine rate response drugs bortezomib (Velcade) vorinostat |
RO4929097 given together capecitabine given together capecitabine treating patients refractory solid tumors . RO4929097 may stop growth tumor cells blocking enzymes needed cell growth . |
Radiolabeled drugs yttrium Y 90 SMT 487 locate tumor cells and deliver tumor-killing substances without harming normal cells . yttrium Y 90 SMT 487 is being tested in Phase I trial study . |
Antiemetic drugs, aprepitant, ondansetron, dexamethasone, may help lessen prevent nausea vomiting patients undergoing stem cell transplant . |
Drugs used chemotherapy, FAU, work different ways stop growth cancer cells . Drugs used chemotherapy, FAU, work different ways stop growth cancer cells . FAU is either killing cells or stopping dividing cells . |
Copanlisib may stop growth tumor cells blocking enzymes needed cell growth . Copanlisib given together nivolumab works treating patients Richter's transformation transformed non-Hodgkin lymphoma . |
10-propargyl-10-deazaaminopterin was used in Phase II trial study . 10-propargyl-10-deazaaminopterin was used to treat patients with non-Hodgkin's |
A significant number patients non-Hodgkin lymphoma (NHL) cured available treatments eventually relapse . Those patients might able tolerate bone marrow toxicity, limiting treatment options . Preclinical vitro studies demonstrated synergism venetoclax cop |
Phase II trial studying effectiveness donor peripheral blood stem cell transplant treating patients hematologic cancer . |
Phase I trial studying side effects of 17-N-allylamino-17-demethoxygeldanamycin . 17-N-allylamino-17-demethoxygeldanamycin treating patients advanced |
Ibrutinib may stop growth cancer cells blocking enzymes needed to grow . This phase I trial studies side effects best dose selinexor given together ibrutinib . |
Drugs used chemotherapy use different ways stop cancer cells dividing stop growing die . Combining chemotherapy peripheral stem cell transplantation may allow doctor give higher doses of drugs kill cancer cells . Monoclonal antibodies locate cancer cells either kill deliver cancer- |
Radiolabeled monoclonal antibodies locate cancer cells deliver cancer-killing substances without harming normal cells . Phase I/II trial study effectiveness radiolabeled monoclonal antibody therapy treating patients lymphoma leukemia responded previous chemotherapy |
Phase II trial studying well topotecan hydrochloride works treating children meningeal cancer . Children's meningeal cancer responded previous treatment . |
The purpose study collect long-term safety efficacy data . Participants treated ibrutinib provide ongoing access to ibrutinib participants currently enrolled ibrutinib studies completed according parent protocol . Participants currently enrolled ibrut |
Bortezomib may stop growth cancer cells blocking enzymes needed to grow . Bortezomib given together gemcitabine may kill cancer cells . |
Phase II trial study effectiveness of combination chemotherapy . Combining one drug may kill tumor cells . Patients with Hodgkin's disease non-Hodgkin's lymphoma responded previous treatment . |
Drugs used chemotherapy use different ways stop cancer cells dividing stop growing die . Combining one drug may kill cancer cells . |
Phase I/II trial studies whether stopping cyclosporine mycophenolate mofetil better reducing risk of graft-versus-host disease (GVHD) previous approach mycophenolate mofetil stopped cycl |
Antimicrobial solution comprising trimethoprim-sulfamethoxazole, edetate calcium disodium, ethanol may help prevent blockages infections forming patients central venous access catheters . |
Ibrutinib may stop growth cancer cells blocking enzymes needed to stop cell growth . It yet known whether safe patients HIV infection receive ibrutinib also taking anti-HIV drugs . |
Keratinocyte growth factor may prevent symptoms mucositis patients receiving radiation therapy chemotherapy . Keratinocyte growth factor may prevent symptoms mucositis patients receiving radiation therapy chemotherapy. |
Combining chemotherapy bone marrow transplantation may allow doctor give higher doses chemotherapy drugs kill cancer cells . Phase II trial study effectiveness combination chemotherapy consisting busulfan cyclophosphamide followed bone marrow transplantation treating patients acute chronic leukemia myelod |
This expanded access protocol conducted sites qualified approved treat subjects lisocabtagene maraleucel . Sometimes lisocabtagene maraleucel manufactured drug pass testing results called lisocabtagene maraleu |
Phase II trial study effectiveness of combination chemotherapy treating patients AIDS-related lymphoma . Drugs used chemotherapy use different ways stop cancer cells dividing stop growing die . Combining one drug may kill cancer cells . |
Phase I/II trial studies side effects of best dose anti-cluster differentiation (CD)20 radioimmunotherapy (RIT) RIT attaches radioactive material drug designed target CD20, brings radioactive material cancer cells kill cells . |
Phase I trial study effectiveness combining topotecan, fluorouracil, leucovorin . Combining one drug may kill tumor cells . |
PDX101 may stop growth cancer cells blocking enzymes needed cell growth blocking blood flow cancer . PDX101 may stop growth cancer cells blocking enzymes needed needed cell growth blocking blood flow cancer . |
GS-0189 (formerly FSI-189) monotherapy combination rituximab participants relapsed/refractory (R/R) non-Hodgkin lymphoma (NHL) participants relapsed/ |
Phase I trial study combining ZD0473 doxorubicin with ZD0473 doxorubicin . Phase I trial study effectiveness combining ZD0473 doxorubicin treating patients advanced solid |
Monoclonal antibodies, rituximab, block cancer growth different ways . Some find cancer cells kill carry cancer-killing substances them . Others interfere ability cancer cells grow spread . Radiation therapy uses high-energy x-rays |
Phase I trial studying side effects of azacitidine plus phenylbutyrate . Trials include patients with advanced metastatic solid tumors who responded to previous treatment . |
Combining one drug giving drugs different ways may kill cancer cells . Radiation therapy uses high-energy x-rays damage cancer cells . It yet known combination chemotherapy regimen followed radiation therapy effective treating aggressive non-Hodgkin's lymphoma |
Monoclonal antibodies, rituximab, block cancer growth different ways . Some find cancer cells kill carry cancer-killing substances . Others interfere ability cancer cells grow spread . |
Motexafin gadolinium may increase effectiveness doxorubicin making tumor cells sensitive drug . Motexafin gadolinium may increase effectiveness doxorubicin making tumor cells sensitive drug . |
NX-5948 patients advanced B-cell malignancies are first in a human dose escalation cohort expansion . The study is designed to evaluate safety preliminary efficacy for advanced B-cell malignancies . |
Monoclonal antibodies rituximab locate cancer cells either kill deliver cancer-killing substances without harming normal cells . Drugs used chemotherapy use different ways stop cancer cells dividing stop growing die . |
This phase 1, open-label, dose-escalation, multicenter study evaluate safety tolerability of SGN-CD19A patients . Patients relapsed refractory B-lineage non-Hodgkin lymphoma |
The trial open-label, multi-center safety preliminary efficacy trial epcoritamab Japan is open-label, multi-center safety preliminary efficacy trial . The purpose dose-escalation part trial determine maximum tolerated dose (MTD |
The purpose study evaluated safety tolerability of BGB-11417 monotherapy . The purpose study evaluated safety tolerability of BGB-11417 monotherapy . The study evaluated BGB-11417 monotherapy selected B-cell mal |
CPI-613 (6,8-bis[benzylthio]octanoic acid) given together bendamustine hydrochloride rituximab . Rituximab may find cancer cells help kill |
Monoclonal antibodies, rituximab, block cancer growth different ways . Some block ability cancer cells grow spread . Others find cancer cells help kill carry cancer-killing substances . |
Monoclonal antibodies rituximab locate cancer cells either kill deliver cancer-killing substances without harming normal cells . Drugs used chemotherapy use different ways stop cancer cells dividing stop growing die . Combining chemotherapy peripheral stem cell transplantation |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.